Ebola outbreak in #DRCongo officially declared Public Health Emergency of International Concern by World Health Organization (WHO) Committee. Full story and details here: news.un.org/en/story/2019/…

Our new analysis on #COVID19 R&D now shows that around US$7.3 billion committed to R&D with some $3.8b for vaccines bit.ly/38W5JQD

Thanks Alison Snyder for highlighting our #COVID19 R&D tracker in Axios #Science newsletter bit.ly/31vJ9Lr

Great piece by Carmen Paun in POLITICO on how "Europe has yet to live up to its #COVID promises," that cites our #COVID R&D tracker showing at least 938 products in the pipeline to fight COVID amongst other great sources noted politi.co/2PKyUgR

Great article by @m_scribe in The New Republic on #COVID19 #vaccines quoting our colleague Dr Vipul Chowdhary

Check it out

We’re closer than ever to developing the next generation of SRH tools and treatments to meet EVERYONE’s needs - but we aren’t there yet. Check out the latest #GFINDER report to learn more about how SRH R&D is paving the way to the future: bit.ly/2Fblzfo

In 2018, $1.7 billion went to reimagining today’s technologies & researching next-generation tools to meet the sexual and reproductive health needs around the 🌎. Learn more: bit.ly/2Fblzfo #GFINDER

Prepared for the next pandemic? Let’s hope so. It starts with R&D. We’re launching our new #GFINDER on the R&D funding landscape for emerging infectious diseases like #Ebola #Zika and more bit.ly/31SN2eG

Check out our new #COVID19 Vaccine Clinical Results Table reviewing the 8 most advanced vaccine candidates bit.ly/33eeliT

Great article by Carmen Paun in POLITICO that cites our #COVID19 R&D tracker and quotes our CEO Dr Nick Chapman: Still wanted: a treatment for the coronavirus politi.co/2DP5gEA

Lassa fever R&D funding grew to $45m in 2018 says new 2020 #GFINDER EID report, largely due to increased funding by CEPI bit.ly/2Fblzfo

More than half of all emerging infectious disease R&D funding between 2014 and 2018 went to #vaccine research 💉, but only 18% to #treatments 💊and less than 4% to #diagnostics 🔬, says new #GFINDER bit.ly/2Fblzfo

The 2020 #GFINDER EID R&D report shows funding to fight #COVID19's cousins, SARS and MERS,was only $41m in 2018 - before the #pandemic hit, but this R&D jumpstarted the #COVID-19 R&D process bit.ly/2Fblzfo

Curious how much governments and industry are spending on R&D to meet the 🌎’s needs to fight emerging infectious diseases that could cause the next #pandemic? 📉 📈Analyse funding trends over time on the #GFINDER data portal: bit.ly/3izbGql

Worth a read #UNGA

Thanks Robin Bisson for the great article in ResearchProfessional on our new #GFINDER on emerging infectious diseases and preventing the next #pandemic Infectious disease funding ‘follows the headlines’ researchprofessionalnews.com/rr-news-world-…

➡️ The #GFINDER data portal provides open access to all underlying data captured in our 2020 sexual and reproductive health R&D report. #UNGA #SRSH #StandUp4HumanRights Check it out: bit.ly/3izbGql

“Together, let's continue #UnitingBusiness for a better world!” – a holiday message from Assistant Secretary-General Sanda Ojiambo, Executive Director & CEO of the UN UN Global Compact: ctt.ec/3Cr29+

In its 22nd year, the UN UN Global Compact launched successful strategies & programmes that helped spread its message and encourage companies to sign on and align their priorities towards #sustainability. Check out these 2022 highlights: express.adobe.com/page/69Kn2Wlb1… #UnitingBusiness